Arterium

arterium.ua

Arterium
The Arterium Corporation operates in the industry which takes care of the most important values – human health and life.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

TASLY PHARMACEUTICALS AND MAUNA KEA TECHNOLOGIES ANNOUNCE JOINT VENTURE AND LICENSING AGREEMENTS

Mauna Kea Technologies | July 12, 2022

news image

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, and Tasly Pharmaceuticals announced the execution of an agreement to form a Joint Venture. Under terms of the agreement, Tasly and Mauna Kea will form a Joint Venture that will (i) commercialize selected Cellvizio indications in China, (ii) develop and commercialize Cellvizio globally in the fields of Neurology and Neurosurgery, and (iii) manufact...

Read More

Business Insights

APPLIED BIOMATH, LLC ANNOUNCES COLLABORATION WITH BYOMASS™ FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | October 18, 2021

news image

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with BYOMass, Inc. for systems pharmacology modeling in chronic diseases. BYOMass is a preclinical stage pharmaceutical company focused on the TGF-ß superfamily. "We chose Applied BioMath given their proven track record of helping companies identify ideal therapeut...

Read More

RECURSION ACQUIRES VIUM STRENGTHENING ITS ATTEMPTS TO INDUSTRIALIZE DRUG DISCOVERY

Recursion, Vium | July 29, 2020

news image

Recursion, a digital biology company leading in the industrialization of drug discovery, today announced its acquisition of Vium, a digital vivarium company. Vium’s platform combines computer vision, machine learning and sensor technologies to non-invasively collect and derive insights from digital biomarkers in preclinical in vivo research. Recursion’s acquisition of Vium signals continued and rapid integration of advanced technologies to grow its drug discovery pipeline of over 30 ...

Read More

Business Insights

VETSOURCE EXPANDS ITS SOLUTION SET TO INCLUDE DATA AND INSIGHTS, CLIENT ENGAGEMENT

Vetsource | February 28, 2022

news image

Vetsource®, a pet health company that provides innovative pharmacy, technology and business services designed to help customers provide products and services to those who care for pets, has added data and insights, and client engagement offerings to its portfolio of customer solutions. Previously focused primarily on the home delivery of prescription and nonprescription items on behalf of veterinary practices, Vetsource has expanded its services in order to build a world-class...

Read More
news image

Business Insights

TASLY PHARMACEUTICALS AND MAUNA KEA TECHNOLOGIES ANNOUNCE JOINT VENTURE AND LICENSING AGREEMENTS

Mauna Kea Technologies | July 12, 2022

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, and Tasly Pharmaceuticals announced the execution of an agreement to form a Joint Venture. Under terms of the agreement, Tasly and Mauna Kea will form a Joint Venture that will (i) commercialize selected Cellvizio indications in China, (ii) develop and commercialize Cellvizio globally in the fields of Neurology and Neurosurgery, and (iii) manufact...

Read More
news image

Business Insights

APPLIED BIOMATH, LLC ANNOUNCES COLLABORATION WITH BYOMASS™ FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | October 18, 2021

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with BYOMass, Inc. for systems pharmacology modeling in chronic diseases. BYOMass is a preclinical stage pharmaceutical company focused on the TGF-ß superfamily. "We chose Applied BioMath given their proven track record of helping companies identify ideal therapeut...

Read More
news image

RECURSION ACQUIRES VIUM STRENGTHENING ITS ATTEMPTS TO INDUSTRIALIZE DRUG DISCOVERY

Recursion, Vium | July 29, 2020

Recursion, a digital biology company leading in the industrialization of drug discovery, today announced its acquisition of Vium, a digital vivarium company. Vium’s platform combines computer vision, machine learning and sensor technologies to non-invasively collect and derive insights from digital biomarkers in preclinical in vivo research. Recursion’s acquisition of Vium signals continued and rapid integration of advanced technologies to grow its drug discovery pipeline of over 30 ...

Read More
news image

Business Insights

VETSOURCE EXPANDS ITS SOLUTION SET TO INCLUDE DATA AND INSIGHTS, CLIENT ENGAGEMENT

Vetsource | February 28, 2022

Vetsource®, a pet health company that provides innovative pharmacy, technology and business services designed to help customers provide products and services to those who care for pets, has added data and insights, and client engagement offerings to its portfolio of customer solutions. Previously focused primarily on the home delivery of prescription and nonprescription items on behalf of veterinary practices, Vetsource has expanded its services in order to build a world-class...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us